Serological immune response against ADAM10 pro-domain is associated with favourable prognosis in stage III colorectal cancer patients

A humoral immune response against aberrant tumor proteins can be elicited in cancer patients, resulting in the production of auto-antibodies (Abs). By serological proteome analysis we identified the surface membrane protein ADAM10, a metalloproteinase that has a role in epithelial-tumor progression...

Descripción completa

Detalles Bibliográficos
Autores principales: Álvarez-Fernández, Sheila María, Barbariga, Marco, Cannizzaro, Luca, Cannistraci, Carlo Vittorio, Hurley, Laura, Zanardi, Alan, Conti, Antonio, Sanvito, Francesca, Innocenzi, Anna, Pecorelli, Nicolò, Braga, Marco, Alessio, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346771/
https://www.ncbi.nlm.nih.gov/pubmed/27517630
http://dx.doi.org/10.18632/oncotarget.11181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346771/
https://www.ncbi.nlm.nih.gov/pubmed/27517630
http://dx.doi.org/10.18632/oncotarget.11181

Ejemplares similares